Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome to the Deep Dive, where we aim for real understanding, not just information.
Today we're getting into the pharmacology behind fighting inflammation and, well, that really nasty crystal -induced pain from gout.
Yeah, our mission today is pretty critical.
We're looking at drugs like NSAIDs, but we're really focusing on the safety aspects,
you know, the FDA warnings, the toxicity issues, and what that means for patient care, pulling directly from our source material.
It's kind of interesting, isn't it?
Inflammation is supposed to be good for you,
protective, walling off injury.
Right, a localized response.
But what the patient feels is just pain,
redness, swelling, heat, can't move properly, those classic signs.
And those signs, they're driven by chemicals.
We've got histamine, bradycanine.
Yeah.
But the big ones really are prostaglandins and leukotrienes.
They're major contributors to the symptoms, according to the source material.
And it all kicks off when injury makes cells release arachidonic acid.
It's like a metabolic crossroads.
Exactly.
Injury happens, arachidonic acid comes out of the cell membrane, and then it splits.
Path 1 uses lipoxygenase and makes leukotrienes.
Which cause vasoconstriction, bronchospasm, not good things.
Definitely not helpful in that context.
And then Path 2, that's the one we're focusing on with NSAIDs, uses the enzyme cyclooxygenase COX to make prostaglandins.
Ah, the prostaglandin pathway.
And those are the culprits behind vasodilation, edema, fever.
Right.
Prostaglandin E2 in the hypothalamus, specifically for fever, and hyperalgesia that increased pain sensitivity, makes everything hurt more.
So NSAIDs arrive on the scene, big diverse group of drugs, analgesic, anti -inflammatory, anti -pyretic, their main job, block COX activity.
But it's not quite that simple, is it?
Because there's Keox1 and Keox2.
And that difference is huge for safety.
Okay, yeah, break that down for us, because understanding this is key to understanding the side effects.
Think of it like this.
COX1 mostly makes good prostaglandins, the ones that protect your stomach lining, keep renal blood flow going, sort of housekeeping functions.
Okay, protective.
While COX2, that one ramps up during inflammation, and makes the prostaglandins that cause the pain, swelling, and fever we want to stop.
Got it.
So the older NSAIDs, the non -selective ones, they hit both Keox1 and Keox2.
Pretty much.
They reduced inflammation,
but by hitting COX1 too, they caused a lot of GI problems.
Stomach ulcers, bleeding.
That was the major downside.
Which led to the development of the selective COX2 inshibitors, like sellotoxin.
The idea was target just the inflammatory COX2, leave the protective Keox1 alone.
Right.
Aim for the benefits with less GI risk.
That's a good idea, but well, as we'll get into, they have their own set of systemic risks.
Not a perfect solution.
We absolutely have to talk about aspirin here, though.
It's technically an NSAID is salicylate, but it does something totally unique.
It really is an outlier.
Its mechanism is different.
It's an irreversible inhibitor of COX1, specifically inside platelets.
And since platelets can't make new enzymes.
That effect lasts for the entire lifespan of the platelet, about 7 to 10 days.
Meaning it powerfully reduces thromboxane A2 formation, which is why it's so vital for anti -clotting.
Low dose aspirin, 81 or 325 milligrams for preventing heart attacks, strokes, and for treating acute MI.
It's a cornerstone therapy there.
So much more than just a pain reliever.
Okay, but this power comes with risks.
The source material highlights some pretty scary numbers, like over 100 ,000 hospitalizations, thousands of deaths every year linked to NSAI use.
These aren't trivial drugs.
No, absolutely not.
And the biggest killer is GI bleeding.
You block those protective COX1 prostaglandins in the stomach.
You damage the mucosa.
That leads to dyspepsia, ulcers, and potentially fatal hemorrhage.
It's the most common cause of death from NSAI use.
Is there anything pharmacologically we can do to sort of counter that GI risk?
Yes, there is.
Mislprostel is often used.
It's a synthetic version of prostaglandin E1.
Ah, so you replace the protective prostaglandin that the NSAID is knocking out.
Exactly.
It helps maintain that mucosal lining and reduces acid secretion.
It's a way to mitigate that specific risk, especially for long -term users.
And the kidneys.
What's the risk there?
Renal function also relies on prostaglandins for things like blood flow regulation.
So NSAIs can disrupt that, leading to potential acute or even chronic renal failure.
Who's most at risk?
Patients who are dehydrated, definitely.
Also those with underlying heart failure, liver problems, or who are already taking diuretics or ACE inhibitors.
Good hydration is really, really important when taking NSAI.
Which brings us squarely to the FDA black box warnings.
This is the highest level of alert.
Crucial information.
Every NSII except aspirin has this warning.
First, there's an increased risk for serious cardiovascular thrombotic events, heart attack, stroke.
And that risk goes up with how long you use them and the dose.
Correct.
And importantly, they are absolutely contraindicated for pain relief right after coronary artery bypass graft surgery.
C -ABG surgery.
Big no -no there.
And the second part of the warning?
That addresses the serious GI risk we just talked about.
Bleeding, ulceration, and perforation of the stomach or intestines.
Again, potentially fatal.
The FDA mandates this warning, which tells you how significant these risks are.
Okay, let's shift slightly from the general NSAID risk to salicylate toxicity specifically.
Salicylism, what does that look like?
With chronic high dose use or even sometimes just prolonged regular use in adults, the classic signs are tinnitus, that ringing in the ears, and some hearing loss.
And in kids.
It presents differently.
More like hyperventilation, CNS effects like dizziness, confusion, behavioral changes.
What if someone takes a massive overdose like swallows a whole bottle?
That's a true emergency.
We often use something called the done nomogram to assess the severity.
A nomogram?
Like a chart?
Yeah, it's a graph.
You plot the patient's serum salicylate level against the time since they ingested the drug.
It helps estimate how bad the poisoning is likely to be.
And guides treatment.
Absolutely.
Based on the nomogram reading, treatment can range from just supportive care and maybe activated charcoal all the way up to hemodialysis if the ingestion was huge, like over 500 milligrams per kilogram.
That nomogram can be life -saving in guiding those decisions.
And speaking of kids, there's one absolute contraindication for aspirin and other salicylates we have to hammer home.
Yes.
Ray's syndrome.
You absolutely do not give aspirin or any salicylate product to children or teenagers who have flu -like symptoms or chicken pox.
Why not?
Because there's a strong link to Ray's syndrome, which is this acute, often fatal condition causing brain swelling and liver damage.
It's rare, but devastating.
So for fever in kids with those symptoms.
Acetaminophen or ibuprofen, never aspirin.
It's a fundamental safety rule.
Okay.
Quick profiles of a couple other key
NSAIDs.
Ketorolac or Toradol, known for being really strong pain relief, almost opioid level.
Yeah.
It's very potent for analgesia.
And importantly, it doesn't have the addictive potential of opioids.
What's the catch?
There's always a catch.
The catch is kidney and GI toxicity.
It's quite harsh on both.
Because of that, its use is strictly limited to a maximum of five days, short -term management of acute pain only, never for minor stuff or chronic pain.
That five -day limit is critical.
Okay.
And then ibuprofen, probably most common one.
Very common, generally considered quite safe relative to others in the class.
It's a propionic acid derivative.
Interestingly, the source material notes that naproxen, another one in that group, might have a slightly better side effect profile.
Maybe fewer interactions with ACE inhibitors compared to ibuprofen.
Something to consider.
And silicoxib, the EOX2 inhibitor.
It's the only COX2 selective inhibitor still widely available.
Use mainly for arthritis, acute pain.
The key thing to remember with silicoxib is the sulfa allergy warning.
Ah, because of its chemical structure.
Exactly.
It's chemically similar to sulfonamide, so if a patient have a known sulfa allergy, silicoxib is contraindicated.
Alright.
That covers the broad anti -inflammatory players.
Let's switch gears now to gout.
What exactly is gout?
Gout is all about uric acid.
It's a type of arthritis caused by hyperuricemia.
Too much uric acid in the blood.
Where does uric acid come from?
It's the end product when your body breaks down purines, which are found in certain foods, and are also just part of normal cell turnover.
And the problem is either making too much or not getting rid of enough.
Precisely.
Either overproduction or, more commonly, the kidneys aren't excreting it efficiently enough.
So the levels build up in the blood.
When then?
When the concentration gets too high, the uric acid forms these tiny, sharp, needle -like crystals.
Monosodium urate crystals.
And they deposit in tissues and joints,
especially cooler areas like the big toe.
Triggering that intense pain and inflammation.
Excruciating pain is a massive inflammatory response to these crystals, like the body is trying to attack these foreign invaders.
Okay.
So if uric acid comes from purine breakdown and there's a key enzyme involved.
Yes.
Xanthine oxidase or XO.
That's the enzyme that converts purines into uric acid.
That's a major drug target.
But for an acute gout attack, the first thing you reach for is probably an NSAID, right?
For the immediate pain and swelling.
Yes.
NSAIDs are generally first -line therapy for the acute flare -up itself.
Reduce that immediate inflammation and pain.
But for long -term management and prevention, we need drugs that target the uric acid problem directly.
Which brings us to the specific anti -gout drugs.
Let's start with the one targeting that XO enzyme.
That would be allopurinol.
It's a xanthine oxidase inhibitor.
It literally stops the enzyme from making uric acid.
So it reduces the overall production.
Who is it best for?
Primarily for patients whose gout is caused by overproduction of uric acid.
What's the biggest safety concern with allopurinol?
It sounds pretty effective.
It is effective, but it carries a serious risk,
potentially fatal skin reactions.
Stevens -Johnson syndrome, SJS, and toxic epidermal necrolysis, TEN.
Wow.
Okay.
So skin assessment is critical.
Absolutely critical.
Nurses need to assess skin thoroughly, and patients must be taught to report any new rash immediately.
It could be the first sign of SJS or TEN.
Okay.
So allopurinol stops production.
What about helping the body get rid of the uric acid it already has?
That's where the uricoceric agents come in, like probenicid.
Uricoceric, meaning it increases uric acid in the urine.
Exactly.
Probenicid works on the renal tubules in the kidney.
It blocks the reabsorption of uric acid back into the blood, forcing more of it to be excreted in the urine.
So this is for patients who under -excrete uric acid.
Correct.
But there's a very important caveat with probenicid.
It relies on decent kidney function to work.
If the patient has significant renal impairment, probenicid just won't be effective and shouldn't be used.
Makes sense.
And the third main anti -gout drug, colchicine, it's an old one.
Very old, yeah.
It's used primarily for acute gout flares, often considered second line after NSAIDs, or for patients who can't take NSAIDs.
Its mechanism is different again.
How does it work?
It doesn't directly affect uric acid levels.
Instead, it reduces the inflammatory response to the crystals that are already there.
It inhibits leukocyte migration, stops the white blood cells from rushing to the joint and causing more inflammation.
So it calms the fire, basically.
That's a good way to put it.
It's generally used short -term for acute attacks, and the dose often needs to be adjusted if the patient has reduced kidney function.
There can be significant GI side effects, too, especially at higher doses.
Okay, let's pull this all together now into the nursing process.
What are the key things nurses or even informed patients need to focus on?
Assessment is step one, always.
You need that thorough history.
Any allergies, especially to aspirin, history of teptic ulcers, bleeding disorders, any existing kidney or liver problems.
What about baseline labs?
Essential.
CBC to check for bleeding risk or anemia, liver function tests, BUN and creatinine for kidney function, and, of course, a baseline serum uric acid level before starting anti -gout therapy.
You mentioned hydration before, especially for kidneys.
How critical is that with anti -gout meds?
Hugely critical, especially with drugs like allopurinol and probenicid that involve uric acid excretion.
You want to keep the urine flowing to prevent uric acid crystals from forming kidney stones.
Aim for good fluid intake, targeting maybe three liters a day if there are no contraindications like heart failure.
Monitor urine output should be at least 30 to 60 mL per hour.
And that aspirin triad again?
Yes.
Always assess for that combo.
Asthma, nasal polyps, and rhinitis.
Patients with a triad have a much higher risk of a serious allergic reaction to aspirin.
Okay.
Implementation and patient teaching.
Key points for NSIIs.
Take them with food, milk, or an antacid.
Always.
Minimizes that direct stomach irritation.
And never crush or chew enteric -coated or sustained release tablets that defeats their protective design.
And patients need to know what to watch for.
Absolutely.
Signs of GI, bleeding black, tarry stools, coffee ground vomit, persistent stomach pain.
Report those immediately.
Also, watch for signs of cardiovascular issues like chest pain or stroke symptoms, especially with long -term use.
And for the anti -gout drugs like allopurinol.
Fluids, fluids, fluids.
Push that intake, like we said, up to three liters a day if possible.
Teach them to avoid alcohol and limit caffeine, as both can increase uric acid levels and work against the medication.
Any other interactions to be aware of?
Generally avoid taking NSIIs with other things that can irritate the stomach, like corticosteroids or even other NSIIs, unless specifically directed by a prescriber.
Alcohol also increases GI irritation risk.
How do we know if these therapies are working?
What does success look like?
For NSIIs used for pain or inflammation.
Decreased pain, less swelling, maybe reduced fever, better ability to do daily activities.
For anti -gout therapy with allopurinol, you want to see that serum uric acid level come into the normal range.
For acute gout treatment,
significant reduction in joint pain and swelling.
Okay, let's recap the big takeaways.
We talked about the key difference between CUREX -1 and CUREX -2.
Why that matters for side effects.
Right, and aspirin's very unique irreversible antiplatelet effect.
Crucial for cardiovascular prevention.
We hit hard on the serious GI and cardiovascular risks of NSIIs, underscored by those FDA black box warnings.
Can't stress those enough.
Definitely not.
And for gout, we outlined the three main strategies.
Inhibiting production with xanthinoxidase inhibitors like allopurinol.
Increasing excretion with urochocerates like probenicid.
And reducing the acute inflammatory response with coltocine or NSIIs.
So here's a final thought to leave you with.
Considering those significant risks, especially the GI and cardiovascular ones with chronic NSAID use,
how do clinicians navigate the really tricky decision of choosing the right long -term pain relief, say for osteoarthritis, particularly in an older adult who might already have other health issues?
It's a complex balancing act, isn't it?
Relief versus potentially serious harm.
It absolutely is.
Lots to weigh up.
Thanks for joining us for this important deep dive today.